editorialtumors of the lymphatic systemtumor progressionprimary lymphosarcomassecondary lymphosarcomasclassificationchemotherapyпередоваяопухоли лимфатической системыопухолевая прогрессияпервичные лимфосаркомывторичные лимфосаркомыклассификацияхимиотерапия1.Воробьев А. И., Бриллиант М. Д. Лимфоцитома селезенки и классификация лимфоцитом. Тер. арх. 1982; 8: 8-14.2.Harris N. L., Jaffe Е. S., Stein H. et al. A Revised European- American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.3.Jaffe E. S., Harris N. L., Stein H. et al. Pathology and genetics of Tumors of haematopoietic and lymphoid tissues. Lyon: I ARC Press; 2001.4.Воробьев А. И. (ред.) Руководство по гематологии. М.: Медицина; 1985.5.Воробьев А. И., Кременецкая А. М., Харазишвили Д. В. Опухоли лимфатической системы. Гематол. и трансфузиол. 2000; 3: 3-14.6.Lenhard R. E., Prentice R. L., Owens A. H. et al. Combination chemotherapy of the malignant lymphomas: a controlled clinical trial. Cancer (Philad.) 1976; 38: 1052-1059.7.Cabanillas F., Rodriguez V., Freireich E. J. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens. Med. Pediatr. Oncol. 1978; 4: 321-331.8.Sweetenham J. W., Pearce R., Taghipour G. et al. Adult Burkitt's and Burkitt's-like non-Hodgkin's lymphoma - outcome for patients treated with high-dose therapy and autologous stem cell transplantation in first remission or at relapse: Results from European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 1996; 14: 2465-2472.9.Popat J., Przepiork D., Champlin R. et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome. Ibid. 1998; 16: 63-69.10.Seidemann K., Tiemann M., Schrappe M. et al. Short-pulse Bnon-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group trial NHL-BFM 90. Blood 2001; 97: 3699-3705.11.Horning S. J., Rosenberg S. A. Natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. L Med. 1984; 311: 1472-1475.12.Longo D. L., What's the deal with follicular lymphomas? J. Clin. Oncol. 1993; 11:202-208.13.Rai K., Peterson B. L., Appelbaum F. R. et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N. Engl. J. Med. 2000; 343: 1750-1757.14.Bergmann L. Present status of purine analogs in the therapy of chronic lymphocytic leukemias. Leukemia 1997; 11 (suppl. 2): 29-34.15.Andrey J., Saven A. Therapeutic advances in the treatment of hiary cell leukemia. Leuk. Res. 2001; 25: 361-368.16.Воробьев А. И., Бриллиант М. Д. Патогенез и терапия лейкозов. М. Медицина; 1976.17.Kimby E., Brandt L., Nygren P. et al. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukemia. Acta, Oncol. 2001; 40: 224-230.18.Воробьев А. П., Бриллиант М. Д. Дифференцированная терапия хронического лимфолейкоза. Тер. арх. 1983; 8: 7-14.19.Pangalis G. A., Angelopoulou М. К., Vassilakopoulos Т. P., et al. Bchronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders. Semin. Hematol. 1999; 36: 104-114.20.Meusers P., Hense J. Management of mantle cell lymphoma. Ann. Hematol. 1999; 78: 485-494.21.Кременецкая А. М., Воробьев А. И., Харазишвили Д. В. Гигантоклеточные лимфосаркомы или вариантные формы лимфогранулематоза? Тер. арх. 2002; 7: 48-52.